P. Roy

发表

Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, Journal of interventional cardiology.

Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three‐vessel coronary artery disease

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic rabbit iliac arteries

R. Virmani, F. Kolodgie, M. Scheinowitz, 2008 .

Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic rabbit iliac arteries.

R. Virmani, F. Kolodgie, M. Scheinowitz, 2008, Journal of interventional cardiology.

Remote Ischemic Preconditioning Acutely Improves Coronary Microcirculatory Function

D. Brieger, L. Kritharides, A. Javadzadegan, 2018, Journal of the American Heart Association.

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2008, The American journal of cardiology.

Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty.

K. Kent, A. Pichard, L. Satler, 2009, Cardiovascular revascularization medicine : including molecular interventions.

Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

The predictive value of computed tomography calcium scores: a comparison with quantitative volumetric intravascular ultrasound.

N. Weissman, G. Mintz, K. Kent, 2008, Cardiovascular revascularization medicine : including molecular interventions.

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents

K. Kent, A. Pichard, L. Satler, 2008 .

The clinical outcome of restricting drug-eluting stents to patients at highest risk of restenosis.

B. Yan, A. Ajani, R. Warren, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors.

G. Lemesle, K. Kent, A. Pichard, 2010, European heart journal.

Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation.

D. Brieger, L. Kritharides, S. Freedman, 2010, International journal of cardiology.

Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Emergence of the concept of platelet reactivity monitoring of response to thienopyridines

G. Lemesle, A. Pichard, P. Barragan, 2009, Heart.

Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.

K. Kent, A. Pichard, L. Satler, 2009, American Journal of Cardiology.

Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions.

G. Lemesle, K. Kent, A. Pichard, 2009, American heart journal.

Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?

K. Kent, A. Pichard, L. Satler, 2007, Catheterization and cardiovascular interventions.

Stenting the vulnerable plaque

R. Waksman, P. Roy, 2007 .

CORONARY ARTERY DISEASE Impact of Bivalirudin Use on Outcomes in Nonagenarians Undergoing Percutaneous Coronary Intervention

G. Lemesle, K. Kent, A. Pichard, 2009 .

Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

In Hospital Outcomes for High-Risk Percutaneous Coronary Intervention (PCI) in Patients Referred From a Rural Centre to Metropolitan Sites.

D. Brieger, M. Adams, L. Kritharides, 2021, Heart, lung & circulation.

Intravascular ultrasound guidance in drug-eluting stent deployment.

R. Waksman, P. Roy, R. Waksman, 2008, Minerva cardioangiologica.

Impact of in-stent restenosis on death and myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Comparison between sirolimus‐ and paclitaxel‐eluting stents in complex patient and lesions subsets

K. Kent, A. Pichard, R. Torguson, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

HOW TO MANAGE PATIENTS WITH LOW RESPONSE TO CLOPIDOGREL Clopidogrel dosage The Intracoronary Stenting and Antithrombotic Regimen : Choose Between 3 High Oral Doses

G. Lemesle, A. Pichard, P. Barragan, 2009 .

Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2008, American Journal of Cardiology.

Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Percutaneous treatment of a giant coronary aneurysm using a Symbiot stent.

A. Ajani, R. Warren, P. Roy, 2005, Cardiovascular revascularization medicine : including molecular interventions.

Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease

K. Kent, A. Pichard, L. Satler, 2007, Circulation.

Successful treatment of a coronary cameral fistula secondary to elective sirolimus-eluting stent implantation.

L. Satler, R. Waksman, Teruo Okabe, 2008, Cardiovascular revascularization medicine : including molecular interventions.

Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Treatment of drug‐eluting stent restenosis with the same versus different drug‐eluting stent

K. Kent, A. Pichard, L. Satler, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries.

K. Kent, A. Pichard, L. Satler, 2007, The American journal of cardiology.

Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.

G. Lemesle, K. Kent, A. Pichard, 2009, Archives of cardiovascular diseases.

Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions.

G. Lemesle, K. Kent, A. Pichard, 2008, The American journal of cardiology.

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.

N. Weissman, K. Kent, A. Pichard, 2008, European heart journal.

Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice.

G. Lemesle, A. Pichard, R. Waksman, 2009, Archives of cardiovascular diseases.

Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device?

K. Kent, A. Pichard, L. Satler, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study.

B. Astor, J. Coresh, C. Ballantyne, 2013, American journal of epidemiology.

Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment.

N. Weissman, G. Mintz, K. Kent, 2007, The American journal of cardiology.

Biodegradable polymer versus second‐generation durable polymer drug‐eluting stents in patients with coronary artery disease: A meta‐analysis

D. Brieger, L. Kritharides, A. Yong, 2018, Health science reports.

Relation of drug-eluting stent strut distribution to stent thrombosis in coronary arteries.

N. Weissman, G. Mintz, K. Kent, 2009, The American journal of cardiology.

Comparison of intravascular ultrasound to contrast-enhanced 64-slice computed tomography to assess the significance of angiographically ambiguous coronary narrowings.

N. Weissman, G. Mintz, K. Kent, 2008, The American journal of cardiology.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts.

N. Weissman, K. Kent, A. Pichard, 2008, The American journal of cardiology.

Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

K. Kent, A. Pichard, L. Satler, 2008, Cardiovascular revascularization medicine : including molecular interventions.

Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, International journal of cardiology.

Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents.

A. Pichard, L. Satler, R. Torguson, 2007, Journal of interventional cardiology.

Vascular brachytherapy for patients with drug-eluting stent restenosis.

G. Lemesle, A. Pichard, L. Satler, 2008, Journal of interventional cardiology.

Abstract 4456: The Impact of Nuisance Bleeding on Clopidogrel Compliance in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

K. Kent, A. Pichard, L. Satler, 2008 .

Investigation of various magnetic features of spinel type cobalt ferrite (CoFe2O4) nanoparticles tuned by annealing temperature

S. M. Hoque, P. Roy, S. Choudhury, 2018, AIP Advances.

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Does creatine kinase‐MB (CK‐MB) isoenzyme elevation following percutaneous coronary intervention with drug‐eluting stents impact late clinical outcome?

K. Kent, A. Pichard, L. Satler, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.